Quest Diagnostics (DGX) Tops Q4 EPS by 7c
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $235.46 -0.02%
EPS Growth %: +10.0%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
SUNB, CULP, KFY, More
EPS Growth %: +10.0%
Financial Fact:
Less: Net income attributable to noncontrolling interests: 13M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.98, $0.07 better than the analyst estimate of $1.91. Revenue for the quarter came in at $2.33 billion versus the consensus estimate of $2.26 billion.
GUIDANCE:
Quest Diagnostics sees FY2023 EPS of $8.40-$9.00, versus the consensus of $8.69. Quest Diagnostics sees FY2023 revenue of $8.83-9.03 billion, versus the consensus of $9.13 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Oddity Tech Ltd. (ODD) Tops Q2 EPS by 1c
- Signet shares jump on Q2 profit beat, raised annual guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
